Skip to main content

Synthetic Biology: What It Is and Why ‘ARKG’ Is So Levered to It

The DNA sequencing and genomics markets move fast. Good news for investors: the ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG) is up to speed. ARKG includes companies that merge healthcare with technology to capitalize on the revolution in genomic sequencing. These companies try to better...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.